HKU Team Finds Way To Treat Covid With Ulcer Drug
"); jQuery("#212 h3").html("
"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1554222_1_20201012174849.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1554222-20201012.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1554222-20201012.htm', 'DCS.dcsqry', '' ); } } }); }); });
2020-10-12 HKT 12:48
Share this story
Researchers at the University of Hong Kong said on Monday that they have found that a way to tackle the novel coronavirus with a drug that is commonly used to treat stomach ulcers.
They said experiments in the laboratory showed that the drug, ranitidine bismuth citrate (RBC), which contains a metal called bismuth, can be used to reduce viral loads in coronavirus-infected cells by over 1,000-fold.
Dr Runming Wang from the university’s Department of Chemistry said the drug is also cheaper and safer than Remdesivir, which is currently used to treat Covid-19.
He said the drug works by targeting a protein in the virus and preventing the virus from replicating.
“As the process of developing an effective vaccine is still ongoing, another approach for preventing and treatment of the disease is to identify anti-Covid-19 agents from existing drugs to repurpose their uses,” he said.
Wang said the drug can be stored at room temperature and without any special requirements.
The team said it had applied for a patent in the US.
Future Fintechs Hong Kong Subsidiary Seeks VASP And Asset Management Licenses
Future Fintech, a financial and digital technology services provider, announced that its wholly owned Hong Kong subsidi... Read more
Can Regulation Scale With Innovation? Inside The Stablecoin Plans Of HK And The U.S.
Back in 2022, stablecoins were still an emerging topic. Yet, they stirred enough flurry for the Hong Kong Monetary Auth... Read more
Cyberport Start-ups Forge Regional Fintech Ties At MyFintech Week 2025 In Malaysia
Cyberport led a delegation of its fintech start-ups to MyFintech Week 2025 (MyFW 2025), held in Kuala Lumpur from 4 to ... Read more
Hong Kongs Stablecoin Law Triggers Industry Concerns Over KYC Rules
Hong Kong’s newly implemented stablecoin law, in effect since 1 August, has sparked concern among some in the industr... Read more
Stopping Fraud At The Gate: The New Imperative For Registration & Transaction Monitoring
The Asia-Pacific fintech landscape is thriving, fueled by the rapid adoption of digital payments, online banking and al... Read more
Hong Kong Private Banks See 14% Growth, Hire 400 More Wealth Managers
Hong Kong’s private banking and wealth management sectors are poised for further growth in hiring and office expansio... Read more